Skip to main content

RHUMBLINE ADVISERS

Position in SMMT — Summit Therapeutics Inc.

CIK 1115418 BOSTON, MA

Position in SMMT

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,848,860
-$607,256 QoQ
Shares Held
126,895
-2.0% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 242 holders
Holding Since
Jun 2021
17 quarters on record
Voting authority Sole 46% Shared 0% None 54%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. SMMT ranks #104 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SMMT

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,848,860 126,895
2026-03-31 $2,456,116 129,542
2025-12-31 $2,122,254 121,341
2025-09-30 $2,539,568 122,922
2025-06-30 $2,604,544 122,394
2025-03-31 $2,541,650 131,760
2024-12-31 $2,234,229 125,202
2024-09-30 $2,623,795 119,808
2024-06-30 $1,003,228 128,619
2024-03-31 $582,262 140,643
2023-12-31 $348,985 133,711
2023-09-30 $249,246 133,287
2023-06-30 $319,337 127,226
2022-03-31 $37,031 15,115
2021-12-31 $34,493 12,823
2021-09-30 $67,264 13,426
2021-06-30 $93,384 12,518